Jerel A. Banks
2024
In 2024, Jerel A. Banks earned a total compensation of $2.8M as Executive Chairman and Chief Executive Officer at Benitec Biopharma, a 205% increase compared to previous year.
Compensation breakdown
| Option Awards | $2,133,085 |
|---|---|
| Salary | $627,900 |
| Other | $37,992 |
| Total | $2,798,977 |
Banks received $2.1M in option awards, accounting for 76% of the total pay in 2024.
Banks also received $627.9K in salary and $38K in other compensation.
Rankings
In 2024, Jerel A. Banks' compensation ranked 9th out of 113 executives tracked by ExecPay. In other words, Banks earned more than 92.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9 out of 113 | 92nd |
Division Manufacturing | 2 out of 50 | 96th |
Major group Chemicals And Allied Products | 1 out of 17 | 94th |
Industry group Drugs | 1 out of 17 | 94th |
Industry Pharmaceutical Preparations | 1 out of 14 | 93rd |
Source: SEC filing on October 23, 2024.
Banks' colleagues
We found one more compensation record of an executive working with Jerel A. Banks at Benitec Biopharma in 2024.
2024
Megan Boston
Benitec Biopharma